Literature DB >> 27694601

Concepts in Cancer Modeling: A Brief History.

Renee M Thomas1, Terry Van Dyke2, Glenn Merlino3, Chi-Ping Day3.   

Abstract

Modeling, an experimental approach to investigate complex biological systems, has significantly contributed to our understanding of cancer. Although extensive cancer research has been conducted utilizing animal models for elucidating mechanisms and developing therapeutics, the concepts in a good model design and its application have not been well elaborated. In this review, we discuss the theory underlying biological modeling and the process of producing a valuable and relevant animal model. Several renowned examples in the history of cancer research will be used to illustrate how modeling can be translatable to clinical applications. Finally, we will also discuss how the advances in cancer genomics and cancer modeling will influence each other going forward. Cancer Res; 76(20); 5921-5. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27694601      PMCID: PMC5117812          DOI: 10.1158/0008-5472.CAN-16-1293

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

Review 1.  The early bird catches the worm: new technologies for the Caenorhabditis elegans toolkit.

Authors:  Xiao Xu; Stuart K Kim
Journal:  Nat Rev Genet       Date:  2011-10-04       Impact factor: 53.242

2.  Can a biologist fix a radio?--Or, what I learned while studying apoptosis.

Authors:  Yuri Lazebnik
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

Review 3.  Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges.

Authors:  Siwen Hu-Lieskovan; Lidia Robert; Blanca Homet Moreno; Antoni Ribas
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

4.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.

Authors:  Stefani Spranger; Riyue Bao; Thomas F Gajewski
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

Review 5.  Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.

Authors:  H E Skipper; S Perry
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

6.  In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents.

Authors:  M C Berenbaum
Journal:  Cancer Chemother Rep       Date:  1972-10

Review 7.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

8.  BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.

Authors:  Richard C Koya; Stephen Mok; Nicholas Otte; Kevin J Blacketor; Begonya Comin-Anduix; Paul C Tumeh; Aspram Minasyan; Nicholas A Graham; Thomas G Graeber; Thinle Chodon; Antoni Ribas
Journal:  Cancer Res       Date:  2012-06-12       Impact factor: 12.701

9.  A history of cancer chemotherapy.

Authors:  Vincent T DeVita; Edward Chu
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

Review 10.  Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies.

Authors:  Jean-Paul Lasserre; Alain Dautant; Raeka S Aiyar; Roza Kucharczyk; Annie Glatigny; Déborah Tribouillard-Tanvier; Joanna Rytka; Marc Blondel; Natalia Skoczen; Pascal Reynier; Laras Pitayu; Agnès Rötig; Agnès Delahodde; Lars M Steinmetz; Geneviève Dujardin; Vincent Procaccio; Jean-Paul di Rago
Journal:  Dis Model Mech       Date:  2015-06       Impact factor: 5.758

View more
  7 in total

1.  CORR Insights®: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.

Authors:  Bruno Fuchs
Journal:  Clin Orthop Relat Res       Date:  2018-07       Impact factor: 4.176

Review 2.  Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance.

Authors:  Chi-Ping Day; Rachel Marchalik; Glenn Merlino; Helen Michael
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

Review 3.  Genetically engineered mouse models of melanoma.

Authors:  Eva Pérez-Guijarro; Chi-Ping Day; Glenn Merlino; M Raza Zaidi
Journal:  Cancer       Date:  2017-06-01       Impact factor: 6.860

4.  Cancer Stem Cells in Tumor Modeling: Challenges and Future Directions.

Authors:  Elvan Dogan; Asli Kisim; Gizem Bati-Ayaz; Gregory J Kubicek; Devrim Pesen-Okvur; Amir K Miri
Journal:  Adv Nanobiomed Res       Date:  2021-06-23

5.  Mathematical Model of Muscle Wasting in Cancer Cachexia.

Authors:  Suzan Farhang-Sardroodi; Kathleen P Wilkie
Journal:  J Clin Med       Date:  2020-06-28       Impact factor: 4.241

6.  Toward improved models of human cancer.

Authors:  Bryan E Welm; Christos Vaklavas; Alana L Welm
Journal:  APL Bioeng       Date:  2021-01-04

Review 7.  Designing Relevant Preclinical Rodent Models for Studying Links Between Nutrition, Obesity, Metabolism, and Cancer.

Authors:  Elaine M Glenny; Michael F Coleman; Erin D Giles; Elizabeth A Wellberg; Stephen D Hursting
Journal:  Annu Rev Nutr       Date:  2021-08-06       Impact factor: 11.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.